The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

StocksUpdated×3•Originally published 4 May 2026•Updated 5 May 2026•

1 min read

Santhera, ADC Therapeutics, and Organto Foods Release Quarterly Earnings Reports

Key Facts

1Santhera Pharmaceuticals Holding AG held its Q4 2025 earnings call.

2ADC Therapeutics SA released its Q1 2026 earnings report.

Healthcare entities Santhera Pharmaceuticals and ADC Therapeutics, along with Organto Foods Inc., have released their latest periodic earnings reports. The financial reporting cycle expanded with Futura Medical plc (FAMDF) publishing its Q4 2025 earnings call transcript, and The Marzetti Company (MZTI) releasing its Q3 2026 results. In a recent update, Schaeffler AG (SFFLY) joined the reporting cluster by releasing its Q1 2026 earnings call transcript. These disclosures reflect the financial health and strategic roadmaps of the companies under prevailing market conditions across the biotech, food, and industrial sectors. Analysts are monitoring these results to assess growth sustainability across their respective product pipelines and market segments. Firms maintain their focus on R&D and operational expansion to navigate the current economic landscape.

30 days ago

Version History

Version 330 days ago

What changed: The report was updated to include the release of Schaeffler AG's (SFFLY) Q1 2026 earnings call transcript.

Version 2about 1 month ago

What changed: Added earnings call transcripts for Futura Medical (FAMDF) and The Marzetti Company (MZTI) to the existing cluster of financial reports.

Version 1about 1 month ago

What changed: Added earnings report information for Organto Foods Inc. (OGOFF) for Q4 2025 and updated the headline to include the new company.